# Ticagrelor vs. Prasugrel Effects on Infarct Size

> **NCT02507323** · PHASE2 · WITHDRAWN · sponsor: **Yochai Birnbaum**

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** ticagrelor
- **DRUG:** prasugrel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02507323
- **Lead sponsor:** Yochai Birnbaum
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-02
- **Primary completion:** 2017-08
- **Final completion:** 2017-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** collaborator withdrew the study
- **Last updated:** 2016-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02507323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02507323, "Ticagrelor vs. Prasugrel Effects on Infarct Size". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02507323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*